RORγt inverse agonist 14
RORγt inverse agonist 14 (8e) is a potent, orally active and selective RORγt inverse agonist (EC50 of 2.5 nM) with anti-inflammatory activity. RORγt inverse agonist 14 is used in the study for rheumatoid arthritis and psoriasis.
For research use only. We do not sell to patients.
- CAS No.: 2672496-70-5
- Formula: C26H26F8N2O6S2
- Molecular Weight:678.61
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
RORγt inverse agonist 14 (8e, 5-20 mg/kg) provides essentially the same arthritic score reduction as a murine equivalent of the marketed TNF decoy receptor etanercept[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Mouse model of psoriasis: acanthosis induced by IL-23[1].
-
Dosage:5, 10, 20 mg/kg.
-
Administration:Orally twice daily.
-
Result:A dose-dependent reduction in ear thickening was observed.
Chemical Information
-
CAS No. 2672496-70-5
-
Molecular Weight 678.61
-
Formula C26H26F8N2O6S2
-
SMILES
O=C(N[C@@H]1CC[C@@]2(S(=O)(C3=CC=C(F)C=C3)=O)C4=C(N=C(C(C(F)(F)F)(F)C(F)(F)F)C=C4)CC[C@]21[H])[C@](C)(O)CS(=O)(C)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)